References

Bademkiran, S. and H.H. Kaya, 2006. Comparison of the beta receptor blockers (carazolol) and PGF2a to prevent the retained placenta in cows due to dystocia. Istanbul Univ. J. Fac. Vet. Med., 32: 69-79.

Baker, J.S., D.M. Bailey, D. Hullin, I. Young and B. Davies, 2004. Metabolic implications of resistive force selection for oxidative stress and markers of muscle damage during 30 sec of high-intensity exercise. Eur. J. Applied Physiol., 92: 321-327.

Bartsch, W., K. Koch, K. Dietmann, H. Leinert and G. Sponer, 1977. Cardiac action of of carazolol and methypranol in comparison with other β-receptor blockers. Arzneimittelforschung, 27: 1022-1026.
PubMed  |  

Costin, B., S.R. O'Donell and J.C. Wanstall, 1983. A comparison of the selectivity of carazolol with that of other β2-adrenoreceptor antagonists. J. Pharm. Pharmacol., 35: 752-754.
PubMed  |  

Mates, J.M., 2000. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology, 153: 83-104.
CrossRef  |  PubMed  |  Direct Link  |  

Mullan, B.A., C.N. Ennis, H.J.P. Fee, I.S. Young and D.R. McCance, 2004. Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia. Am. J. Physiol. Heart Circ. Physiol., 287: H1262-H1268.
PubMed  |  

Sun, Y., L.W. Oberley and Y. Li, 1988. A simple method for clinical assay of superoxide dismutase. Clin. Chem., 34: 497-500.
CrossRef  |  Direct Link  |  

Yasmineh, W.G., T.P. Kaur, B. Blazar and A. Theologides, 1995. Serum catalase as marker of graft-vs-host disease in allogeneic bone marrow transplant recipients: Pilot study. Clin. Chem., 41: 1574-1580.
PubMed  |  

Yoshioka, T., K. Kawada, T. Shimada and M. Mori, 1979. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am. J. Obstet. Gynecol., 135: 372-376.
CrossRef  |  PubMed  |  Direct Link  |